Tocilizumab-effects on growth impairment in systemic juvenile idiopathic arthritis

被引：0
|
作者：
Takako Miyamae
Tomo Nozawa
Masako Kikuchi
Toshitaka Kizawa
Tomoyuki Imagawa
Shumpei Yokota
机构：
[1] Yokohama City University,Department of Pediatrics
来源：
Pediatric Rheumatology | / 9卷 / Suppl 1期
关键词：
Tocilizumab; Standard Deviation Score; Corticosteroid Dose; Growth Impairment; Systemic Juvenile Idiopathic Arthritis;
D O I：
10.1186/1546-0096-9-S1-P130
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Tocilizumab for the treatment of systemic juvenile idiopathic arthritis
    Herlin, Troels
    EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2012, 8 (06) : 517 - 525
  • [2] Effect of Tocilizumab on growth impairment in systemic juvenile idiopathic arthritis with long-term corticosteroid therapy
    Miyamae, Takako
    Yokoya, Susumu
    Yamanaka, Hisashi
    Yokota, Shumpei
    MODERN RHEUMATOLOGY, 2014, 24 (04) : 567 - 571
  • [3] Tocilizumab in the treatment of systemic juvenile idiopathic arthritis
    Murakami, Miho
    Tomiita, Minako
    Nishimoto, Norihiro
    OPEN ACCESS RHEUMATOLOGY-RESEARCH AND REVIEWS, 2012, 4 : 71 - 79
  • [4] Clinical pharmacology of tocilizumab for the treatment of systemic juvenile idiopathic arthritis
    Zhang, Xiaoping
    Morcos, Peter N.
    Saito, Tomohisa
    Terao, Kimio
    EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 2013, 6 (02) : 123 - 137
  • [5] Successful use of tocilizumab in amyloidosis secondary to systemic juvenile idiopathic arthritis
    Ayush Gupta
    Narendra Kumar Bagri
    Saroj Kumar Tripathy
    Adarsh Barwad
    Ravi Hari Phulware
    Pankaj Hari
    Rheumatology International, 2020, 40 : 153 - 159
  • [6] Successful use of tocilizumab in amyloidosis secondary to systemic juvenile idiopathic arthritis
    Gupta, Ayush
    Bagri, Narendra Kumar
    Tripathy, Saroj Kumar
    Barwad, Adarsh
    Phulware, Ravi Hari
    Hari, Pankaj
    RHEUMATOLOGY INTERNATIONAL, 2020, 40 (01) : 153 - 159
  • [7] Tocilizumab: molecular intervention therapy in children with systemic juvenile idiopathic arthritis
    Yokota, Shumpei
    Kishimoto, Tadamitsu
    EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2010, 6 (05) : 735 - 743
  • [8] Efficacy, safety and tolerability of tocilizumab in patients with systemic juvenile idiopathic arthritis
    Yokota, Shumpei
    Tanaka, Toshio
    Kishimoto, Tadamitsu
    THERAPEUTIC ADVANCES IN MUSCULOSKELETAL DISEASE, 2012, 4 (06) : 387 - 397
  • [9] Sequential Tocilizumab and Tofacitinib Treatment for Systemic Juvenile Idiopathic Arthritis: a Case Report
    Ye Zhang
    Jinli Ru
    Jinxiu Zhang
    Rheumatology and Therapy, 2023, 10 : 293 - 300
  • [10] Risk factors for hypersensitivity reactions to tocilizumab introduction in systemic juvenile idiopathic arthritis
    Yasuoka, Ryuhei
    Iwata, Naomi
    Abe, Naoki
    Kohagura, Toaki
    Nakaseko, Haruna
    Shimizu, Masaki
    Kawabe, Shinji
    MODERN RHEUMATOLOGY, 2019, 29 (02) : 324 - 327
12345